Adiponectin protects against the development of systolic dysfunction following myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 6, 2007, Pages 1065-1074

  Shibata, Rei ^a   Izumiya, Yasuhiro ^a   Sato, Kaori ^a   Papanicolaou, Kyriakos ^a   Kihara, Shinji ^b   Colucci, Wilson S ^a   Sam, Flora ^a   Ouchi, Noriyuki ^a   Walsh, Kenneth ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Heart failure; Ischemia; Myocytes; Ventricular function

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN; BETA GALACTOSIDASE; CD31 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HEART DISEASE; HEART HYPERTROPHY; HEART INFARCTION; MALE; MOUSE; MYOCARDIAL INTERSTITIAL FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SYSTOLIC DYSFUNCTION;

ADENOVIRIDAE; ADIPONECTIN; ANIMALS; APOPTOSIS; BLOOD PRESSURE; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROSIS; GENETIC VECTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

ADENOVIRIDAE; MUS;

EID: 34249670301     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.03.808     Document Type: Article

References (44)

1. Rutter M.K., Parise H., Benjamin E.J., Levy D., Larson M.G., Meigs J.B., et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107 (2003) 448-454
2. Wolk R., Berger P., Lennon R.J., Brilakis E.S., and Somers V.K. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 108 (2003) 2206-2211
3. Lauer M.S., Anderson K.M., Kannel W.B., and Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266 (1991) 231-236
4. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347 (2002) 305-313
5. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
6. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
7. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
8. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler., Thromb., Vasc. Biol. 20 (2000) 1595-1599
9. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler., Thromb., Vasc. Biol. 23 (2003) 85-89
10. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
11. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
12. Okamoto Y., Kihara S., Ouchi N., Nishida M., Arita Y., Kumada M., et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002) 2767-2770
13. Ohashi K., Kihara S., Ouchi N., Kumada M., Fujita K., Hiuge A., et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47 (2006) 1108-1116
14. Shibata R., Ouchi N., Kihara S., Sato K., Funahashi T., and Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J. Biol. Chem. 279 (2004) 28670-28674
15. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10 (2004) 1384-1389
16. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11 (2005) 1096-1103
17. Takahashi T., Saegusa S., Sumino H., Nakahashi T., Iwai K., Morimoto S., et al. Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis. J. Int. Med. Res. 33 (2005) 207-214
18. George J., Patal S., Wexler D., Sharabi Y., Peleg E., Kamari Y., et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92 (2006) 1420-1424
19. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
20. Ingelsson E., Riserus U., Berne C., Frystyk J., Flyvbjerg A., Axelsson T., et al. Adiponectin and risk of congestive heart failure. JAMA 295 (2006) 1772-1774
21. Anker S.D., Ponikowski P., Varney S., Chua T.P., Clark A.L., Webb-Peploe K.M., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
22. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
23. Pfeffer J.M., Pfeffer M.A., Fletcher P.J., and Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. 260 (1991) H1406-H1414
24. Scherrer-Crosbie M., Ullrich R., Bloch K.D., Nakajima H., Nasseri B., Aretz H.T., et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104 (2001) 1286-1291
25. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., and Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101 (2000) 660-667
26. Izumiya Y., Shiojima I., Sato K., Sawyer D.B., Colucci W.S., and Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47 (2006) 887-893
27. Anker S.D., and Rauchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr. Opin. Cardiol. 14 (1999) 211-216
28. Mosterd A., Cost B., Hoes A.W., de Bruijne M.C., Deckers J.W., Hofman A., et al. The prognosis of heart failure in the general population: the Rotterdam Study. Eur. Heart J. 22 (2001) 1318-1327
29. Rauchhaus M., Koloczek V., Volk H., Kemp M., Niebauer J., Francis D.P., et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int. J. Cardiol. 76 (2000) 125-133
30. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13 (2002) 134-141
31. Liao Y., Takashima S., Maeda N., Ouchi N., Komamura K., Shimomura I., et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc. Res. 67 (2005) 705-713
32. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115 (2005) 2108-2118
33. Shiojima I., and Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20 (2006) 3347-3365
34. Karch R., Neumann F., Ullrich R., Neumuller J., Podesser B.K., Neumann M., et al. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy. Cardiovasc. Pathol. 14 (2005) 135-144
35. Bauersachs J., Galuppo P., Fraccarollo D., Christ M., and Ertl G. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation 104 (2001) 982-985
36. Li Y., Takemura G., Kosai K., Yuge K., Nagano S., Esaki M., et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 107 (2003) 2499-2506
37. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98 (1998) 2800-2804
38. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94 (2004) e27-e31
39. Ouchi N., Kobayashi H., Kihara S., Kumada M., Sato K., Inoue T., et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279 (2004) 1304-1309
40. Cohn J.N., Ferrari R., and Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35 (2000) 569-582
41. Esposito G., Rapacciuolo A., Naga Prasad S.V., Takaoka H., Thomas S.A., Koch W.J., et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105 (2002) 85-92
42. Fujioka D., Kawabata K., Saito Y., Kobayashi T., Nakamura T., Kodama Y., et al. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am. J. Physiol.: Heart Circ. Physiol. 290 (2006) H2409-H2416
43. MacLellan W.R., and Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 81 (1997) 137-144
44. Sam F., Sawyer D.B., Chang D.L., Eberli F.R., Ngoy S., Jain M., et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H422-H428